Miyata Hiroaki, Shiraishi Hiromi, Kai Ichiro
Department of Healthcare Quality Assessment, Graduate School of Medicine, University of Tokyo, Japan.
BMC Med Ethics. 2006 Oct 18;7:E11. doi: 10.1186/1472-6939-7-11.
Japanese people have become increasingly interested in the expression and enhancement of their individual autonomy in medical decisions made regarding medical treatment at and toward the end of life. However, while many Western countries have implemented legislation that deals with patient autonomy in the case of terminal illness, no such legislation exists in Japan. The rationale for this research is based on the need to investigate patient's preferences regarding treatment at the end of life in order to re-evaluate advance directives policy and practice.
We conducted a cross-sectional survey with 418 members of the general middle-aged and senior adults (aged between 40 and 65) in Tokyo, Japan. Respondents were asked about their attitudes toward advance directives, and preferences toward treatment options.
Over 60% of respondents agreed that it is better to express their wishes regarding advance directives (treatment preferences in writing, appointment of proxy for care decision making, appointment of legal administrator of property, stating preferences regarding disposal of one's property and funeral arrangements) but less than 10% of them had already done so. About 60% of respondents in this study preferred to indicate treatment preferences in broad rather than concrete terms. Over 80% would like to decide treatment preferences in consultation with others (22.2% with their proxy, 11.0% with the doctor, and 47.8% with both their proxy and the doctor).
This study revealed that many Japanese people indicate an interest in undertaking advance directives. This study found that there is a range of preferences regarding how advance directives are undertaken, thus it is important to recognize that any processes put into place should allow flexibility in order to best respect patients' wishes and autonomy.
日本人越来越关注在临终医疗决策中表达和增强个人自主权。然而,尽管许多西方国家已实施针对绝症患者自主权的立法,但日本尚无此类立法。本研究的理论依据是,需要调查患者对临终治疗的偏好,以便重新评估预立医疗指示政策和实践。
我们对日本东京418名普通中老年人(年龄在40至65岁之间)进行了横断面调查。受访者被问及他们对预立医疗指示的态度以及对治疗选择的偏好。
超过60%的受访者同意最好表达他们对预立医疗指示的意愿(以书面形式表达治疗偏好、指定护理决策代理人、指定财产法定管理人、说明财产处置和葬礼安排的偏好),但其中不到10%的人已经这样做了。本研究中约60%的受访者更喜欢以宽泛而非具体的方式表明治疗偏好。超过80%的人希望与他人协商决定治疗偏好(22.2%与他们的代理人、11.0%与医生、47.8%与他们的代理人及医生协商)。
本研究表明,许多日本人表示有兴趣制定预立医疗指示。本研究发现,在如何制定预立医疗指示方面存在一系列偏好,因此重要的是要认识到,任何实施的程序都应具有灵活性,以便最好地尊重患者的意愿和自主权。